PHARMACEUTICAL INDUSTRY SYMPOSIUM 9 BY SANDOZ
RIXATHON® development and real world evidence data - by Sandoz
| Experiences from real clinical practice in Serbia – efficacy and safety of Sandoz rituximab biosimilar | Doc. D-r Darko Antić, UKC Serbia Belgrade |
| Clinical development and main clinical data supporting the use of RIXATHON® | Dr Martin Ivanovski, UC of hematology Skopje |